Gain TherapeuticsGANX
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 25 institutions reported holding Gain Therapeutics Inc. (GANX) in their 13F filings, up 6 from Q3 2024. 10 opened new positions and 4 sold out. The largest holders were Gotham Asset Management ($3.7M), Greenlight Capital (DME Capital Management) ($1.2M) and Geode Capital Management, LLC ($578K). 3 famous investors held it, including David Einhorn (0.1% of Greenlight Capital (DME Capital Management)'s portfolio), Joel Greenblatt (0.0% of Gotham Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Gain Therapeutics Inc.
- CUSIP
- 36269B105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $624K |
| Exits | 4 | $114K |
All 13F filers, Q3 2024 → Q4 2024: 553,749 shares bought and 245,296 shares sold, net +308,453 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Gotham Asset Management | 0.04% | Reduce -52.7% | 158,155 | $3.7M |
| Greenlight Capital (DME Capital Management) | 0.06% | No change | 566,130 | $1.2M |
| Geode Capital Management, LLC | 0.00% | Reduce -1.7% | 267,421 | $578K |
| Vanguard Group Inc. | 0.00% | Add +21.9% | 177,075 | $382K |
| Jones Financial Companies LLLP | 0.00% | Add +83.6% | 98,250 | $212K |
| Marshall Wace, LLP | 0.00% | New | 91,738 | $198K |
| Morgan Stanley | 0.00% | Add +1744.0% | 88,512 | $191K |
| BlackRock, Inc. | 0.00% | Add +1.3% | 86,061 | $186K |
| Northern Trust Corp. | 0.00% | Add +88.2% | 84,586 | $183K |
| State Street Corp. | 0.00% | Add +106.6% | 71,137 | $154K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 54,500 | $118K |
| Susquehanna International Group, LLP | 0.00% | New | 46,913 | $101K |
| Prelude Capital Management, LLC | 0.01% | No change | 35,820 | $77K |
| UBS Group AG | 0.00% | Add +316.6% | 35,227 | $76K |
| Bridgeway Capital Management, LLC | 0.00% | New | 30,004 | $65K |
| Royal Bank of Canada | 0.00% | New | 17,500 | $38K |
| Benedict Financial Advisors Inc. | 0.01% | New | 16,000 | $35K |
| Sandhill Capital Partners LLC | 0.00% | No change | 15,400 | $33K |
| Sprott Inc. | 0.00% | New | 14,000 | $30K |
| Citadel Advisors | 0.00% | New | 11,612 | $25K |
| Creekmur Asset Management LLC | 0.00% | No change | 4,440 | $10K |
| MAI Capital Management | 0.00% | New | 4,410 | $10K |
| Bank of America Corp. | 0.00% | Add +14.0% | 4,085 | $9K |
| Wells Fargo & Company | 0.00% | No change | 2,650 | $6K |
| Citigroup Inc. | 0.00% | New | 2,000 | $4K |
"% of holder's portfolio" is GANX's weight in each manager's 13F, not the share of Gain Therapeutics Inc. the manager owns.